Antibiotic prophylaxis in ureteroscopy-time for a good quality randomised controlled trial?

Hettiarachchi, Dinul; Rogers, Alistair; Veeratterapillay, Rajan; Harding, Chris

Hettiarachchi, Dinul; Rogers, Alistair; Veeratterapillay, Rajan; Harding, Chris.

Affiliation

Hettiarachchi D; The Medical School, Newcastle University, Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK. d.hettiarachchilage@ncl.ac.uk.
Rogers A; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
Veeratterapillay R; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
Harding C; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.

World J Urol ; 39(7): 2809-2810, 2021 Jul.

Article in En | MEDLINE | ID: mdl-32424514

Subject(s)

Anti-Bacterial Agents/therapeutic use; Antibiotic Prophylaxis; Bacterial Infections/prevention & control; Ureteroscopy/adverse effects; Antimicrobial Stewardship; Bacterial Infections/etiology; Drug Resistance, Bacterial; Humans; Randomized Controlled Trials as Topic; Ureteroscopy/instrumentation; Ureteroscopy/methods; Urologic Diseases/diagnosis; Urologic Diseases/surgery

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Infections / Ureteroscopy / Antibiotic Prophylaxis / Anti-Bacterial Agents Limits: Humans Language: En Journal: World J Urol Year: 2021 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google